Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Gommern

7 clinical trials in Gommern, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Gommern at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Gommern

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma GmbH

Rheumatoid arthritis

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rosnilimab
  • Sponsor:Anaptysbio Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Gommern

What the registry says about research in the country

01 Autoimmune Disorders

Clinical research focusing on Systemic Lupus Erythematosus (SLE), evaluating innovative therapies for patients with moderate to severe disease activity. Studies are examining long-term safety and effectiveness of new treatment approaches.

  • Long-term treatment evaluation
  • Standard of care enhancement
  • Disease activity management

Investigations aim to improve quality of life for patients with chronic autoimmune conditions.

02 Rheumatic Conditions

Research initiatives targeting Rheumatoid Arthritis and Giant Cell Arteritis, exploring new therapeutic options for patients with moderate to severe symptoms. Studies focus on novel treatment approaches and disease management strategies.

  • Clinical efficacy assessment
  • Remission maintenance
  • Treatment optimization

Trials aim to advance treatment options and improve outcomes for patients with inflammatory conditions.

03 Inflammatory Muscle Disorders

Innovative research examining treatment options for dermatomyositis, investigating oral therapies for extended periods. Studies focus on symptom management and long-term therapeutic solutions.

  • Extended treatment evaluation
  • Symptom management
  • Safety assessment

Research aims to develop effective treatments for patients with inflammatory muscle conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.